Therapeutic studies in NZB-W mice. I. Synergy of azathioprine, cyclophosphamide and methylprednisolone in combination.
D000818:Animals; D001379:Azathioprine / Q000008:administration & dosage / Q000627:therapeutic use*; D001835:Body Weight; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000627:therapeutic use*; D004195:Disease Models, Animal; D004357:Drug Synergism; D005260:Female; D005921:Glomerulonephritis / Q000188:drug therapy* / Q000473:pathology; D006400:Hematocrit; D007165:Immunosuppression Therapy; D007678:Kidney Glomerulus / Q000473:pathology; D007958:Leukocyte Count; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D008775:Methylprednisolone / Q000008:administration & dosage / Q000627:therapeutic use*; D051379:Mice; D011507:Proteinuria / Q000139:chemically induced
D003520:Cyclophosphamide; D001379:Azathioprine; D008775:Methylprednisolone